40 related articles for article (PubMed ID: 16939939)
1. A qualitative assessment of injection drug use and harm reduction programmes in Kabul, Afghanistan: 2006-2007.
Todd CS; Stibich MA; Stanekzai MR; Rasuli MZ; Bayan S; Wardak SR; Strathdee SA
Int J Drug Policy; 2009 Mar; 20(2):111-20. PubMed ID: 18207381
[TBL] [Abstract][Full Text] [Related]
2. Harm Minimisation Drug Policy Implementation Qualities: Their Efficacy with Australian Needle and Syringe Program Providers and People Who Inject Drugs.
Resiak D; Mpofu E; Rothwell R
Healthcare (Basel); 2022 Apr; 10(5):. PubMed ID: 35627918
[TBL] [Abstract][Full Text] [Related]
3. Injecting and Sexual Networks and Sociodemographic Factors and Dual HIV Risk among People Who Inject Drugs: A Cross-sectional Study in Kermanshah Province, Iran.
Noroozi M; Mirzazadeh A; Noroozi A; Sharifi H; Higgs P; Jorjoran-Shushtari Z; Farhoudian A; Fadai F; Mohhamadi-Shahboulaghi F; Armoon B; Hajebi A; Massah O
Addict Health; 2016 Jul; 8(3):186-194. PubMed ID: 28496957
[TBL] [Abstract][Full Text] [Related]
4. Patterns of HIV Risks and Related Factors among People Who Inject Drugs in Kermanshah, Iran: A Latent Class Analysis.
Sharifi H; Mirzazadeh A; Noroozi A; Marshall BD; Farhoudian A; Higgs P; Vameghi M; Mohhamadi Shahboulaghi F; Qorbani M; Massah O; Armoon B; Noroozi M
J Psychoactive Drugs; 2017; 49(1):69-73. PubMed ID: 27937534
[TBL] [Abstract][Full Text] [Related]
5. Comparing the cost effectiveness of harm reduction strategies: a case study of the Ukraine.
Kim SW; Pulkki-Brannstrom AM; Skordis-Worrall J
Cost Eff Resour Alloc; 2014; 12():25. PubMed ID: 25873788
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C avoidance in injection drug users: a typology of possible protective practices.
McGowan C; Harris M; Rhodes T
PLoS One; 2013; 8(10):e77038. PubMed ID: 24194855
[TBL] [Abstract][Full Text] [Related]
7. Reduction in HCV incidence among injection drug users attending needle and syringe programs in Australia: a linkage study.
Iversen J; Wand H; Topp L; Kaldor J; Maher L
Am J Public Health; 2013 Aug; 103(8):1436-44. PubMed ID: 23763399
[TBL] [Abstract][Full Text] [Related]
8. Patterns of injection drug use cessation during an expansion of syringe exchange services in a Canadian setting.
Werb D; Kerr T; Buxton J; Shoveller J; Richardson C; Montaner J; Wood E
Drug Alcohol Depend; 2013 Oct; 132(3):535-40. PubMed ID: 23642315
[TBL] [Abstract][Full Text] [Related]
9. Analysis of duration of risk behaviour for key populations: a literature review.
Fazito E; Cuchi P; Mahy M; Brown T
Sex Transm Infect; 2012 Dec; 88 Suppl 2(Suppl_2):i24-32. PubMed ID: 23172343
[TBL] [Abstract][Full Text] [Related]
10. Differences in substance-related risk behavior between dual and triple diagnosed severely mentally ill adults.
Hampton MD; Chafetz L; Portillo C
Ment Health Subst Use; 2012 Feb; 5(1):52-63. PubMed ID: 22582086
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence and correlates of HIV and HCV among injecting drug users in Edmonton, Alberta.
Plitt SS; Gratrix J; Hewitt S; Conroy P; Parnell T; Lucki B; Pilling V; Anderson B; Choudri Y; Archibald CP; Singh AE
Can J Public Health; 2010; 101(1):50-5. PubMed ID: 20364539
[TBL] [Abstract][Full Text] [Related]
12. Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia.
Vorobjov S; Uusküla A; Abel-Ollo K; Talu A; Rüütel K; Des Jarlais DC
Harm Reduct J; 2009 Feb; 6():3. PubMed ID: 19232088
[TBL] [Abstract][Full Text] [Related]
13. Patterns of drug use and associated harms among rural injecting drug users: comparisons with metropolitan injecting drug users.
Day C; Conroy E; Lowe J; Page J; Dolan K
Aust J Rural Health; 2006 Jun; 14(3):120-5. PubMed ID: 16706881
[TBL] [Abstract][Full Text] [Related]
14. Is point of access to needles and syringes related to needle sharing? Comparing data collected from pharmacies and needle and syringe programs in south-east Sydney.
Bryant J; Topp L; Hopwood M; Iversen J; Treloar C; Maher L
Drug Alcohol Rev; 2010 Jul; 29(4):364-70. PubMed ID: 20636651
[TBL] [Abstract][Full Text] [Related]
15. Client satisfaction and risk behaviours of the users of syringe dispensing machines: a pilot study.
Islam M; Stern T; Conigrave KM; Wodak A
Drug Alcohol Rev; 2008 Jan; 27(1):13-9. PubMed ID: 18034377
[TBL] [Abstract][Full Text] [Related]
16. Needle syringe acquisition and HIV prevention among injecting drug users: a treatise on the "good" and "not so good" public health practices in South Asia.
Panda S; Sharma M
Subst Use Misuse; 2006; 41(6-7):953-77. PubMed ID: 16809181
[TBL] [Abstract][Full Text] [Related]
17. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews.
Palmateer N; Kimber J; Hickman M; Hutchinson S; Rhodes T; Goldberg D
Addiction; 2010 May; 105(5):844-59. PubMed ID: 20219055
[TBL] [Abstract][Full Text] [Related]
18. Comparison of needle and syringe programme attendees and non-attendees from a high drug-using area in Sydney, New South Wales.
Cao W; Treloar C
Drug Alcohol Rev; 2006 Sep; 25(5):439-44. PubMed ID: 16939939
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
